Pembrolizumab: Uses, Dosage, Side Effects & Warning - Drugs.com
WEBMar 26, 2024 · Pembrolizumab is a type of immunotherapy used to treat cancers, including lung cancer, breast cancer, melanoma, head and neck cancer, and many more. Pembrolizumab works by helping your immune system to slow or stop the growth and spread of cancer cells in the body.
Pembrolizumab - Wikipedia
WEBPembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 Inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer.
Pembrolizumab - NCI - National Cancer Institute
WEBPembrolizumab is a type of targeted therapy drug called an immune checkpoint inhibitor (a type of immunotherapy). It is a monoclonal antibody that binds to the protein PD-1 on the surface of immune cells called T cells. It works by keeping cancer cells from suppressing the immune system.
Pembrolizumab - StatPearls - NCBI Bookshelf
WEBJun 26, 2023 · Pembrolizumab is a humanized monoclonal IgG4 kappa antibody directed against human cell surface PD-1 (programmed death receptor-1) on lymphocytes. The PD-1 receptor provides an important “immune checkpoint,” which helps prevent the immune system from attacking itself.
Keytruda: Uses, Dosage, Side Effects, Warnings - Drugs.com
WEBSep 9, 2024 · Keytruda (pembrolizumab) is an immunotherapy medication that may be used to treat at least 18 different types of cancer such as melanoma, non-small cell lung cancer (NSCLC), head and neck squamous cell cancer (HNSCC), classical Hodgkin Lymphoma, endometri.
Keytruda (pembrolizumab): Side effects, uses, cost, and more
WEBJun 27, 2024 · Keytruda is a brand-name intravenous infusion prescribed for certain types of cancer. Keytruda contains the active ingredient pembrolizumab and is a type of immunotherapy.
Pembrolizumab (Keytruda): Uses & Side Effects - Cleveland Clinic
WEBPembrolizumab is a monoclonal antibody that treats certain types of cancer. The brand name of this medication is Keytruda®. A healthcare provider will give you this infusion in a hospital or clinic setting. What is this medication? PEMBROLIZUMAB (pem broe liz ue mab) is a monoclonal antibody. It is used to treat certain types of cancer.
Pembrolizumab - Macmillan Cancer Support
WEBPembrolizumab (Keytruda®) is an immunotherapy drug used to treat melanoma, non-small cell lung cancer, Hodgkin lymphoma and bladder cancer.
Pembrolizumab (Intravenous Route) Description and Brand Names - Mayo Clinic
WEBJul 1, 2024 · Pembrolizumab is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or under the direct supervision of your doctor. This product is available in the following dosage forms:
Pembrolizumab: Side Effects, Uses, Dosage, Interactions, Warnings - RxList
WEBJun 21, 2024 · What Is Pembrolizumab and How Does It Work? Pembrolizumab is a prescription medication indicated for the treatment of: unresectable or metastatic melanoma. non-small cell lung cancer (NSCLC) head and neck squamous cell carcinoma (HNSCC) classical Hodgkin lymphoma (cHL) primary mediastinal large B-Cell lymphoma (PMBCL) urothelial carcinoma (UC)
Skip to content